Skip to content
Subscriber Only
Business
Prognosis

Pfizer-BioNTech Can Supply 3 Billion Vaccine Doses This Year

Bloomberg business news
Inside a Pfizer Vaccine Production Facility
Updated on

BioNTech SE and Pfizer Inc. have the capacity to make as many as 3 billion doses of their Covid-19 vaccine this year, lifting their production target even as pressure mounts to waive their patents to boost global supply.

In 2022, the partners will further increase their capacity to more than 3 billion doses, BioNTech said in an e-mailed statement. Though the production goals aren’t the same as firm orders, the increases more than double what the partners had said they’d be able to make less than six months ago.